Alpha 2B or 2B/2C adrenoceptor agonists for the treatment of neurodegeneration

Details for Australian Patent Application No. 2009238370 (hide)

Owner Allergan, Inc.

Inventors Wheeler, Larry A.; Donello, John E.; Gil, Daniel W.

Agent Davies Collison Cave

Pub. Number AU-B-2009238370

Parent 2003282758

Filing date 20 November 2009

Wipo publication date 17 December 2009

Acceptance publication date 21 July 2011

International Classifications

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/00 (2006.01)

A61K 31/4174 (2006.01)

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 December 2009 Complete Application Filed

17 December 2009 Application Open to Public Inspection

  Published as AU-B-2009238370

21 July 2011 Application Accepted

  Published as AU-B-2009238370

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009238371-Improvements in hearing aid algorithms

2009238369-Thrombin compositions